Predicting low biota to sediment accumulation factors of PAHs by using infinite-sink and equilibrium extraction methods as well as BC-inclusive modeling

Sequestration of polycyclic aromatic hydrocarbons (PAHs) results in the slow release of PAHs from sediment to the aqueous environment, thus limiting bioavailability. Three methods to account for the limited bioavailability of native PAHs to the gastropod Hinia reticulata were therefore investigated: (i) infinite-sink extractions that measure desorption; (ii) equilibrium extractions that measure freely dissolved pore water concentrations and (iii) black carbon-inclusive modeling. The rapidly desorbing fraction was estimated based on the amount desorbed by Tenax. Relatively small amounts of PAHs (<9%) were present in F(rapid) and the observed solid-water distribution ratios (K(d,obs)) were approximately 1-2 orders of magnitude higher than literature K(oc) values. Biota to sediment accumulation factors (BSAFs) measured in the gastropod H. reticulata ranged from 0.02 to 0.07, 10-140 times lower than the theoretical value of approximately 1-2. The BSAFs calculated using the rapidly desorbing fraction or freely dissolved aqueous concentrations were also much lower than the theoretical value, and median values differed from the measured BSAFs by only a factor of 1.5-9. Furthermore, the result of using a BC-inclusive BSAF model could explain the deviation from the theoretical BSAF value and account for the low bioavailability of these native PAHs to H. reticulata. Risk assessment strategies of in situ contamination should therefore include a combination of chemical methods accounting for bioavailability, as well as bioaccumulation studies.     

Noninvasive prenatal screening for cystic fibrosis using circulating trophoblasts: Detection of the 50 most common disease-causing variants

Objectives

Cystic fibrosis (CF) is one of the most common severe autosomal recessive disorders. Prenatal or preconception CF screening is offered in some countries. A maternal blood sample in early pregnancy can provide circulating trophoblasts and offers a DNA source for genetic analysis of both the mother and the fetus. This study aimed to develop a cell-based noninvasive prenatal test (NIPT) to screen for the 50 most common CF variants.

Methods

Blood samples were collected from 30 pregnancies undergoing invasive diagnostics and circulating trophoblasts were harvested in 27. Cystic fibrosis testing was conducted using two different methods: by fragment length analysis and by our newly developed NGS-based CF analysis.

Results

In all 27 cases, cell-based NIPT provided a result using both methods in agreement with the invasive test result.

Conclusion

This study shows that cell-based NIPT for CF screening provides a reliable result without the need for partner- and proband samples.